Kallmann syndrome in females: gonadotropin versus GnRH to induce fertility.
Kallmann syndrome is characterized by hypogonadotropic hypogonadism and anosmia. We observed the improvement of gonadal failure upon exposure to gonadotropin, but not gonadotropin-releasing hormone, in the female patients.
Imai
A
A
Department of Obstetrics and Gynecology, Gifu University School of Medicine, Japan.
Tamaya
T
T
D000293:Adolescent; D005260:Female; D005300:Fertility Agents, Female / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone / Q000627:therapeutic use*; D006062:Gonadotropins / Q000627:therapeutic use; D006801:Humans; D017436:Kallmann Syndrome / Q000628:therapy*; D008596:Menotropins / Q000627:therapeutic use
D005300:Fertility Agents, Female; D006062:Gonadotropins; D007987:Gonadotropin-Releasing Hormone; D008596:Menotropins